长期口服华法林腹股沟疝患者不停药行Lichtenstein手术治疗的安全性分析

Safety analysis of long-term oral warfarin in perioperative patients undergoing Lichtenstein hernia repair

目的探讨长期口服华法林患者不停药行Lichtenstein手术治疗的可行性及安全性。方法回顾性分析2019年1月至2020年6月,中国科学技术大学附属第一医院收治及手术的口服华法林腹股沟疝患者4例,分析总结患者在围手术期不停药行Lichtenstein手术的安全性及随访结果。结果 4例接受华法林抗凝治疗的腹股沟疝患者均未停药接受腹股沟疝Lichtenstein修补术,术后2~5 d痊愈出院,随访1周至16个月,无术后血肿、感染及复发。结论对于接受华法林治疗的腹股沟疝患者围手术期不停药行腹股沟疝Lichtenstein修补术可能是一个安全有效的选择。

Objective To explore the feasibility and safety of Lichtenstein hernia repair in patients on chronic warfarin therapy.Methods From January 2019 to June 2020,four patients with inguinal hernia treated with oral warfarin in our department were analyzed retrospectively.The safety and follow-up results of the patients during the perioperative period were summarized.Results Four patients with inguinal hernia received anticoagulation therapy with warfarin in our department,all of them received Lichtenstein hernia repair of inguinal hernia without stopping medication,and all of them were cured and discharged from the hospital.During the follow-up from 1 week to 16 months,there was no hematoma,infection or recurrence.Conclusion Continuation of warfarin may be a safe alternative in patients undergoing Lichtenstein herniorraphy.